Back to search
Monocarboxylate Transporter 8 (MCT8) Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Monocarboxylate Transporter 8 (MCT8) Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Monocarboxylate Transporter 8 (MCT8) Deficiency trials you may qualify forThe Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to su…
Thyroid hormones (TH) play a pivotal role in the development and function of the mammalian brain. Patients with impaired thyroid hormone transport into the brai…
The goal of this program is to provide expanded access (i.e., before marketing authorization) to tiratricol as treatment for patients with monocarboxylate trans…
This is a double-blind, randomized phase 3 multicenter placebo-controlled study in at least 16 evaluable male participants diagnosed with MCT8 deficiency. Male…
This study will investigate the effect of treatment with tiratricol (also called Triac) in young boys (≤30 months) with MCT8 deficiency (also called the Allan-H…